SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Comment Letter for Intec Bioplastics, Inc. (CIK 0002030337) — Jan 27, 2026

Intec Bioplastics, Inc. (CIK 0002030337)
Date: Jan. 27, 2026 · CIK: 0002030337 · Accession: 0000000000-26-000985

Offering / Registration Process Regulatory Compliance Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 024-12706

Date
January 26, 2026
Author
Hector Hernandez
Form
UPLOAD
Company
Intec Bioplastics, Inc. (CIK 0002030337)

Letter

January 26, 2026 Hector Hernandez Chief Executive Officer Intec Bioplastics, Inc. 10648 Painter Ave. Santa Fe Springs, CA 90670 Re:Intec Bioplastics, Inc. Offering Statement on Form 1-A Filed January 21, 2026 File No. 024-12706 Dear Hector Hernandez: This is to advise you that we do not intend to review your offering statement. We will consider qualifying your offering statement at your request. If a participant in your offering is required to clear its compensation arrangements with FINRA, please have FINRA advise us that it has no objections to the compensation arrangements prior to qualification. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257 of Regulation A requires you to file periodic and current reports, including a Form 1-K which will be due within 120 calendar days after the end of the fiscal year covered by the report. Please contact Jane Park at 202-551-7439 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:David Hunt, Esq.

Show Raw Text
January 26, 2026
Hector Hernandez
Chief Executive Officer
Intec Bioplastics, Inc.
10648 Painter Ave.
Santa Fe Springs, CA 90670
Re:Intec Bioplastics, Inc.
Offering Statement on Form 1-A
Filed January 21, 2026
File No. 024-12706
Dear Hector Hernandez:
            This is to advise you that we do not intend to review your offering statement.
            We will consider qualifying your offering statement at your request. If a participant in
your offering is required to clear its compensation arrangements with FINRA, please have
FINRA advise us that it has no objections to the compensation arrangements prior to
qualification.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257
of Regulation A requires you to file periodic and current reports, including a Form 1-K which
will be due within 120 calendar days after the end of the fiscal year covered by the report.
            Please contact Jane Park at 202-551-7439 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and Services
cc:David Hunt, Esq.